Chang E - Search Results

1

Mxi1 influences cyst formation in three-dimensional cell culture.

Yook YJ, Yoo KH, Song SA, Seo MJ, Ko JY, Kim BH, Lee EJ, Chang E, Woo YM, Park JH. Yook YJ, et al. Among authors: chang e. BMB Rep. 2012 Mar;45(3):189-93. doi: 10.5483/BMBRep.2012.45.3.189. BMB Rep. 2012. PMID: 22449707 Free article.

2

Differential Expression of PKD2-Associated Genes in Autosomal Dominant Polycystic Kidney Disease.

Yook YJ, Woo YM, Yang MH, Ko JY, Kim BH, Lee EJ, Chang ES, Lee MJ, Lee S, Park JH. Yook YJ, et al. Genomics Inform. 2012 Mar;10(1):16-22. doi: 10.5808/GI.2012.10.1.16. Epub 2012 Mar 31. Genomics Inform. 2012. PMID: 23105924 Free PMC article.

3

Targeting of receptor for advanced glycation end products suppresses cyst growth in polycystic kidney disease.

Park EY, Kim BH, Lee EJ, Chang E, Kim DW, Choi SY, Park JH. Park EY, et al. Among authors: chang e. J Biol Chem. 2014 Mar 28;289(13):9254-62. doi: 10.1074/jbc.M113.514166. Epub 2014 Feb 10. J Biol Chem. 2014. PMID: 24515114 Free PMC article.

4

Restoring multidrug resistance-associated protein 3 attenuates cell proliferation in the polycystic kidney.

Chang E, Park EY, Woo Ym, Kang DH, Hwang YH, Ahn C, Park JH. Chang E, et al. Am J Physiol Renal Physiol. 2015 May 1;308(9):F1004-11. doi: 10.1152/ajprenal.00159.2014. Epub 2014 Aug 20. Am J Physiol Renal Physiol. 2015. PMID: 25143454 Free article.

5

Soluble receptor for advanced glycation end products inhibits disease progression in autosomal dominant polycystic kidney disease by down-regulating cell proliferation.

Lee EJ, Park EY, Mun H, Chang E, Ko JY, Kim DY, Park JH. Lee EJ, et al. Among authors: chang e. FASEB J. 2015 Aug;29(8):3506-14. doi: 10.1096/fj.15-272302. Epub 2015 May 1. FASEB J. 2015. PMID: 25934702

6

Targeting of miR34a-NOTCH1 axis reduced breast cancer stemness and chemoresistance.

Park EY, Chang E, Lee EJ, Lee HW, Kang HG, Chun KH, Woo YM, Kong HK, Ko JY, Suzuki H, Song E, Park JH. Park EY, et al. Among authors: chang e. Cancer Res. 2014 Dec 15;74(24):7573-82. doi: 10.1158/0008-5472.CAN-14-1140. Epub 2014 Nov 3. Cancer Res. 2014. PMID: 25368020

7

A novel miR-34a target, protein kinase D1, stimulates cancer stemness and drug resistance through GSK3/β-catenin signaling in breast cancer.

Kim do Y, Park EY, Chang E, Kang HG, Koo Y, Lee EJ, Ko JY, Kong HK, Chun KH, Park JH. Kim do Y, et al. Among authors: chang e. Oncotarget. 2016 Mar 22;7(12):14791-802. doi: 10.18632/oncotarget.7443. Oncotarget. 2016. PMID: 26895471 Free PMC article.

8

Characterization of the von Willebrand factor/factor VIII complex produced by a novel purification process.

Ahn JW, Chang ES, Jung YJ, Kim SR, Seong BL, Ha SH. Ahn JW, et al. Arch Pharm Res. 2020 Jul;43(7):714-723. doi: 10.1007/s12272-020-01245-y. Epub 2020 Jul 14. Arch Pharm Res. 2020. PMID: 32666302

9

Antibiotic-Induced Gut Microbiota Dysbiosis Modulates Host Transcriptome and m⁶A Epitranscriptome via Bile Acid Metabolism.

Yang M, Zheng X, Fan J, Cheng W, Yan TM, Lai Y, Zhang N, Lu Y, Qi J, Huo Z, Xu Z, Huang J, Jiao Y, Liu B, Pang R, Zhong X, Huang S, Luo GZ, Lee G, Jobin C, Eren AM, Chang EB, Wei H, Pan T, Wang X. Yang M, et al. Among authors: chang eb. Adv Sci (Weinh). 2024 May 7:e2307981. doi: 10.1002/advs.202307981. Online ahead of print. Adv Sci (Weinh). 2024. PMID: 38713722

10

Advancements and future directions in positron emission tomography-guided radiotherapy: a narrative review.

Mehta S, Yang C, Jadvar H, Colletti PM, Conti PS, Ma L, Chang EL, Ye JC. Mehta S, et al. Among authors: chang el. Chin Clin Oncol. 2024 Apr;13(2):24. doi: 10.21037/cco-23-143. Chin Clin Oncol. 2024. PMID: 38711177 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,544 results

Search Page